“It is a positive move and will help in ease of doing business,” said Deepnath Roy Chowdhury, president of Indian Drug Manufacturers' Association (IDMA). Cipla declined to comment, while other firms did not respond to queries on the issue. “The NPPA was sitting on applications and was not clearing ...
Read more: Eased NPPA drug approvals to inject growth into sector